| Takdang panahon | Hinulaang Presyo | nakaraan | Makasaysayan | Pananaw |
|---|---|---|---|---|
| Bukas | $10.53 ▲ +1.33% | Kahapon | $10.33 ▼ -0.56% | Tomorrow's Zevra Therapeutics Inc. Common Stock (ZVRA) setup is anchored to $10.39 and targets $10.53 (+1.33%). The near-term read is upside; watch $10.70 / $10.08 because daily realized volatility is about 6.84%. |
Tomorrow's Zevra Therapeutics Inc. Common Stock (ZVRA) setup is anchored to $10.39 and targets $10.53 (+1.33%). The near-term read is upside; watch $10.70 / $10.08 because daily realized volatility is about 6.84%. | ||||
| Linggo | $10.82 ▲ +4.12% | Noong nakaraang Linggo | $10.21 ▼ -1.73% | The 7-day Zevra Therapeutics Inc. Common Stock model moves from $10.21 to $10.82 (+4.12%). It gives upside momentum context for this stock, so breaks around $10.70 / $10.08 matter more than a single tick. |
The 7-day Zevra Therapeutics Inc. Common Stock model moves from $10.21 to $10.82 (+4.12%). It gives upside momentum context for this stock, so breaks around $10.70 / $10.08 matter more than a single tick. | ||||
| buwan | $11.30 ▲ +8.79% | Noong nakaraang Buwan | $10.01 ▼ -3.69% | The 1-month Zevra Therapeutics Inc. Common Stock target is $11.30 (+8.79%), compared with the live reference near $10.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Zevra Therapeutics Inc. Common Stock target is $11.30 (+8.79%), compared with the live reference near $10.39. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| taon | $12.03 ▲ +15.77% | Noong nakaraang taon | $9.70 ▼ -6.62% | The 1-year Zevra Therapeutics Inc. Common Stock scenario points to $12.03 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Zevra Therapeutics Inc. Common Stock scenario points to $12.03 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Taon | $13.73 ▲ +32.14% | 5 Taon Nakaraan | $8.99 ▼ -13.50% | The 5-year Zevra Therapeutics Inc. Common Stock view is $13.73 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Zevra Therapeutics Inc. Common Stock view is $13.73 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Tagapagpahiwatig | Halaga | Signal |
|---|---|---|
| Price | $10.39 | Mid |
| Daily Change | -3.62% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $10.39 | Daily Change | -3.62% |
| Market Cap | $610.01M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.